Inhibition of smooth muscle myosin as a novel therapeutic target for hypertension

Keyphrases

• Hypertension 100%
• Amlodipine 100%
• Smooth muscle Myosin 100%
• Novel Therapeutic Targets 100%
• Renal Blood Flow 75%
• Cardiac Output 50%
• Mean Arterial Pressure 50%
• Myosin Inhibitor 50%
• Blood Flow 25%
• Rodent Models 25%
• Small Molecules 25%
• Minimal Impact 25%
• Adverse Effects 25%
• Novel Therapeutics 25%
• Ultrasonic 25%
• US Patents 25%
• Vasodilator 25%
• Renal Insufficiency 25%
• Left Ventricular End-diastolic Pressure 25%
• Renal Artery 25%
• Ascending Aorta 25%
• Calcium Channel Blockers 25%
• Antihypertensive Drugs 25%
• Renal Hypertension 25%
• Vasodilation 25%
• Renal Transplant Recipients 25%
• Iliac 25%
• Pressure Gauge 25%
• Oral Administration 25%
• Ca2+ Channel Blockers 25%
• Patients with Hypertension 25%
• Drug Mechanism 25%
• Regional Blood Flow 25%
• Peripheral Edema 25%
• Limb Blood Flow 25%
• Conscious Dogs 25%
• Patients with Heart Failure 25%
• Flow Probe 25%
• Aortic Pressure 25%
• Pressure Catheter 25%
• Total Peripheral Resistance 25%
• Patent Publications 25%
• Afterload Reduction 25%
• Hypertensive 25%
• Alkylurea 25%
• Iliac Artery 25%
• Direct Inhibitors 25%

Veterinary Science and Veterinary Medicine

• Amlodipine 100%
• Renal Blood Flow 75%
• Cardiac Output 50%
• Dog 50%
• Mean Arterial Pressure 50%
• Ventricular Pressure 25%
• Calcium Channel Blocker 25%
• Vascular Resistance 25%
• Total Peripheral Resistance 25%
• Aortic Pressure 25%
• Small Molecule 25%
• Afterload 25%
• Ascending Aorta 25%
• Renovascular Hypertension 25%
• Vasodilation 25%

Pharmacology, Toxicology and Pharmaceutical Science

• Myosin 100%
• Amlodipine 100%
• Heart Failure 25%
• Peripheral Edema 25%
• Kidney Failure 25%
• Antihypertensive Agent 25%
• Renovascular Hypertension 25%
• Vasodilator Agent 25%
• Side Effect 25%
• Drug Action 25%
• Channel Blocker 25%
• Calcium Channel Blocker 25%